South America Leukapheresis Market
No. of Pages: 116 | Report Code: TIPRE00025793 | Category: Life Sciences
No. of Pages: 116 | Report Code: TIPRE00025793 | Category: Life Sciences
The South America Leukapheresis market is analyzed based on three large countries: Brazil, Argentina, and rest of SAM. Brazil is contributing a major share in the growth of leukapheresis market. In Brazil, sickle cell is among the most common hereditary diseases. Every year, 700 to 1000 children in Brazil are known to be born with SCD. The disease’s most common type is sickle cell anemia (SCA), which occurs due to a single mutation in the β-globin gene. In Brazil, the occurrence of sickle cell anemia is varied, with a significantly higher incidence in states such as Maranhão with higher poverty indexes and more significant numbers among individuals of African descent. The country has also recorded a rise in the cases of leukemia among children during recent years. The cases of leukemia in Brazil have increased with time and at present, is the 9th most common cancer in the country. Its prevalence is found to be considerably high among males and causes from 41.7 to 57.5 cases per million inhabitants. Also, the proportion of leukemia cases among regions is highly variable in the country and has risen since the last report by published the Instituto Nacional do Câncer (INCA). The Northern part of Brazil was identified to have the second-highest number of leukemia cases. It also has the lowest municipal human development index (mHDI), hence leading the highest childhood mortality rate. Therefore, owing to the rise in cases of sickle cell anemia and leukemia, the country is expected to offer growth opportunities for the market during the forecast period.
South America have been witnessing a growing number of COVID-19 cases since its outbreak. The cases are increasing in Brazil, Argentina, and Colombia. The COVID-19 is expected to result in the region's worst recession, causing a 9.1% contraction in regional GDP in 2020. This is expected to increase the number of poor up by 45 million and the extremely poor number by 28 million. The COVID? 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South America. It suffers from severe inequalities. State-run hospitals and clinics are already overstressed by the treatment of vector?borne diseases and community?acquired infections and high rates of non?communicable diseases (NCDs). Moreover, in South America, the Gross Domestic Product (GDP) and central government healthcare expenditure are significantly lower than in developed countries. In 2018, as per the United Nations, Economic Commission for Latin America (CEPAL), 16 South American countries invested less than 4% of their GDP to healthcare. The consequences of a lack of investment in public healthcare systems are reflecting during the pandemic. The COVID?19 pandemic is exacerbating these inequalities by threatening the infrastructure and capacity of state?owned healthcare systems. Thus, the factors mentioned above are negatively impacting the growth of the market in the region.
Strategic insights for the South America Leukapheresis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 4.92 Million |
| Market Size by 2028 | US$ 7.89 Million |
| Global CAGR (2021 - 2028) | 7.0% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
The geographic scope of the South America Leukapheresis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The leukapheresis market in South America is expected to grow from US$ 4.92 million in 2021 to US$ 7.89 million by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028. Blood diseases disturb the overall well-being of patients. Anemia; hemophilia; von Willebrand disease (VWD); blood cancers such as myeloma, leukemia, and lymphoma are among the common blood diseases. The number of newly diagnosed leukemia cases increased from 354,500 in 1990 to 518,500 in 2017. According to the Centers of Disease Control and Prevention (CDC), hemophilia A affects ~1 in 5,000 male births. The CDC survey for 2017 reported that Von Willebrand disease (VWD), one of the most commonly occurring bleeding disorders, affects up to 1% of the population. More than 14,600 men, women, and children were seen at hemophilia treatment centers for the treatment of VWD during 2012–2016. The rising incidence of these diseases maximizes the need for blood transfusion, thereby bolstering the demand for leukapheresis equipment. Two of the most common types of apheresis used for the removal of harmful substances from blood are cytapheresis and plasma exchange. Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, and multiple sclerosis. Cytapheresis, a process that removes the excess number of blood cells, is used in the treatment of leukemia, polycythemia, and thrombocythemia, among others.
In terms of product type, the leukapheresis disposables segment held a larger share in 2021. Based on application, research applications segment held the largest share in 2021. Based on end user, blood component providers and blood centers segment held the largest share in 2021.
A few major primary and secondary sources referred to for preparing this report on the leukapheresis market in South America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Haemonetics Corporation; Terumo Corporation; STEMCELL Technologies Inc.; HemaCare; Macopharma; AllCells; and BioIVT among others.
The South America Leukapheresis Market is valued at US$ 4.92 Million in 2021, it is projected to reach US$ 7.89 Million by 2028.
As per our report South America Leukapheresis Market, the market size is valued at US$ 4.92 Million in 2021, projecting it to reach US$ 7.89 Million by 2028. This translates to a CAGR of approximately 7.0% during the forecast period.
The South America Leukapheresis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Leukapheresis Market report:
The South America Leukapheresis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Leukapheresis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Leukapheresis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Leukapheresis Market
